Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 2 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report ...
New COVID Mystery? Those 'Excess Deaths'
newser· 2 days agoWith hospitals swamped at the same time, excess deaths spiked considerably from causes including heart disease, stroke, and diabetes. COVID vaccines...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 6 days agoThis combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 3 days agoCombination vaccines have been successfully used for several decades in Australia and around the...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 6 days agoHere's what we know about the newest vaccines so far. The Food and Drug Administration on Friday...
Vanguard Group Inc. Sells 210,463 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 18 hours agoVanguard Group Inc. lessened its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 0.0% during the fourth quarter, according to its most recent filing with the Securities ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 2 days agoThis underperformance of Pfizer stock can be attributed to declining revenues after the surge in Covid-19 vaccine demand during the pandemic ...
